Clinical Trial Update: Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 study evaluating anti-atherosclerotic and estrogen-like activity of Karinat in perimenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Menopause

Drugs mentioned

• Karinat

Snippet

Sponsor: Institute for Atherosclerosis Research, Russia | Conditions: Menopausal Syndrome, Atherosclerosis | Phase 3 | Status: COMPLETED